Value Bridge — ENLOE MEDICAL CENTER
Current $-4M → Target $14M (+$18.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-4.3M
Current EBITDA
$14.1M
Target EBITDA
+$18.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.2M
Payer Mix Optimization
$10.0M
Cost to Collect Reduction
$3.3M
Clean Claim Improvement
$2.5M
Volume & Rate Growth
$16.7M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-4M to $14M. The highest-impact lever is Volume & Rate Growth at $6.7M probability-weighted.
IC talking point: "We see $18M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $203M in equity value creation."